Skip to main content
Open Forum Infectious Diseases logoLink to Open Forum Infectious Diseases
. 2025 Jul 11;12(8):ofaf409. doi: 10.1093/ofid/ofaf409

Individual- and Neighborhood-Level Predictors of HIV Care Continuum Progression: Clark County, Nevada

R Goyal 1,✉,2, A Wells 2, V Burris 3, A Stachnik 4, P Tang 5, L Collins 6, S R Mehta 7,8, J Dufresne 9, S J Little 10,
PMCID: PMC12363390  PMID: 40838258

Abstract

Background

As the US human immunodeficiency virus (HIV) epidemic is disproportionately affecting underserved communities, it is critically important to investigate how social determinants of health affect diagnosis, treatment, and prevention of HIV infection and access to care. This article presents an investigation of the HIV epidemic in Clark County, Nevada, to identify local predictors of progression along the HIV care continuum.

Methods

Deidentified HIV surveillance data from 2011 to 2022 were analyzed. We investigated associations between stages of care and individual-level demographics and zip code–level characteristics using (1) generalized linear mixed-effects models for univariate analysis, (2) penalized generalized linear mixed-effects models to simultaneously conduct variable selection and estimation for multivariate analysis, and (3) geospatial analysis.

Results

Individual-level factors (diagnosis year, age at diagnosis, being Hispanic, being a man who has sex with men, sex at birth, and individual-level membership in a genetic cluster) and zip code–level factors (genetic clustering and social determinants of health, including level of poverty, proportion Hispanic, proportion with high school education, proportion white, and employment status) were associated with progression through the care continuum. A key result from our multivariate analysis is higher-poverty areas are associated with lower rates of persons with HIV in care (estimate [SE], −0.42 [0.17]; P = .02) and viral suppression (−0.48 [0.15]; P = .001).

Conclusions

Our findings highlight the need for linking and engaging individuals in higher-poverty neighborhoods to medical providers. Furthermore, our results support the need for additional treatment adherence services in those same neighborhoods to increase viral suppression rates.

Keywords: HIV care continuum, late-stage diagnoses, poverty, social determinants of health, viral suppression


Efforts to combat the human immunodeficiency virus (HIV) epidemic have evolved significantly over the past decades, leading to remarkable reductions in new HIV infections [1]. While this achievement should be applauded, the epidemic in the United States is increasingly disproportionately concentrated among underserved communities [2]. Given this context, there is increased interest in investigating how social determinants of health (SDOH)—“the nonmedical conditions that influence health outcomes” [3]—affect diagnosis, treatment, and overall management of HIV infection [4–8].

The HIV care continuum, also known as the HIV treatment cascade, provides a comprehensive framework to assess the progress of individuals with HIV from diagnosis to sustained viral suppression [9]. Understanding the individual-level characteristics and broader SDOH factors that influence progression along the care continuum is crucial for developing effective interventions and optimizing HIV care delivery. Several epidemiologic studies have examined associations between SDOH and the HIV care continuum progression for large geographic regions (eg, national) [5, 10, 11]. However, a more recent systematic review has shown that investigating the unique dynamics and predictors of progression in specific geographic areas is essential as the influence of neighborhood factors on progression through the HIV care continuum varies by geographic region and the demographics of people with HIV (PWH) [12]. The majority of studies included in the review indicated that care continuum outcomes were associated with local conditions, including distance to care in Washington, DC [13], and neighborhood poverty in New York City [14]. However, several studies, including in Chicago [15], South Carolina [16], and Florida [17], did not find an association between social and economic deprivation and HIV care continuum outcomes. Furthermore, such local understanding is potentially necessary for tailoring interventions to address local challenges [18].

This article presents an analysis of predictors of progression along the HIV care continuum for Clark County, Nevada. Clark County is one of the 48 priority jurisdictions for the Ending the HIV Epidemic initiative [19]. In 2022, there were 11 518 PWH living in Clark County, resulting in a prevalence of 487 per 100 000 population [20]. In 2022, there were 21 new HIV diagnoses per 100 000 population, with a total of 488 new cases identified across the county [20]. Clark County has the highest number and rate of PWH of any county in Nevada [21], and it ranks seventh highest among US counties in terms of new HIV diagnoses rates [22].

We identified individual-level characteristics and SDOH associated with progression along the HIV care continuum in Clark County. In particular we assessed factors that could influence timely HIV diagnosis, being in care, and achievement of viral suppression. To achieve this objective, we conducted a comprehensive analysis of deidentified data collected from the Clark County Enhanced HIV/AIDS Reporting System (eHARS), an application that assists health departments with reporting, data management, analysis, and data sharing.

METHODS

Data

We studied 3597 PWH who had HIV diagnosed in Clark County between 2011 and 2022 and resided in Clark County on 31 December 2022. Residence is based on zip code of diagnosis and current address available in eHARS. Restricting the analysis to individuals who both received their diagnosis and lived in Clark County enables better isolation of the association between local predictors and progression along the HIV care continuum. For each individual, we analyzed deidentified demographic characteristics (such as race, transmission risk, and age), residential zip codes (at diagnosis and most recent, as of 2022), clinical laboratory values (specifically CD4+ T-lymphocyte count and viral load), and HIV sequence data.

These sequences were HIV-1 partial pol sequences collected for antiretroviral resistance testing in the course of routine clinical care, as ordered by clinicians in Clark County. The sequences were processed by different laboratories but eventually entered into eHARS, from which our analyses were performed. Population statistics that represent aspects of SDOH factors at the zip code level (including race, ethnicity, poverty, employment, and education) were obtained from the American Community Survey (ACS) 2021 report (5-year averages were used). Locations of HIV testing sites supported by Southern Nevada Health District (SNHD) were provided by SNHD.

All studies were reviewed and approved by the University of California San Diego Human Research Protections Program. The study conducted secondary data analysis, and no additional primary data were collected from participants. Data were anonymized before they were received from Clark County.

Outcomes

We identified individual-level characteristics and zip code–level SDOH associated with (1) late-stage diagnosis; (2) being in care; and (3) achievement of viral suppression. HIV infection stages were classified according to the Centers for Disease Control and Prevention (CDC) surveillance case definitions, which delineate stages 0–3 based on CD4+ cell count. Stage 0 denotes early HIV infection, identified by a negative HIV test result within 180 days preceding a confirmed positive result [23]. Stages 1, 2, and 3 are characterized by a CD4+ cell counts of ≥500/µL, 200–499/µL, and <200/µL, respectively [23]. In this study, we designated an individual as having a late-stage diagnosis ​if both HIV and HIV stage 3 were diagnosed within 90 days of each other; this definition is consistent with previous research published by CDC [24].

We defined being in care as having a viral load, CD4+ cell count, or HIV genotype laboratory result during 2022 or the last quarter of 2021. We assumed that PWH were virally suppressed if their viral load was <200 copies/mL of blood on a visit; this definition is consistent with the metric for viral suppression used by the CDC [25]. We used the last observed viral load in the calendar year of 2022 if >1 was observed. If an individual did not have a viral load result during 2022, we included values that occurred in the last quarter of 2021. If neither of these periods included a viral load, the person was considered not virally suppressed.

Predictors

We investigated individual-level characteristics as well as SDOH factors represented by zip code–level population characteristics. For individual-level characteristics, we investigated ethnicity and race (Hispanic of any race, black non-Hispanic, white non-Hispanic, and other non-Hispanic [eg, Asian, Native American]), whether the individual reported as a man who has sex with men or a person who injects drugs, age at HIV diagnosis, year of diagnosis, sex at birth, and whether an individual's HIV sequence is sufficiently similar to another individual in Clark County to be considered genetically linked (ie, genetically clustering with ≥1 other individual). To assess linkage, we computed genetic distances between viral sequences using the TN93 nucleotide substitution model [26]. Sufficient similarity was inferred when the genetic distance between the 2 sequences were below a distance threshold of 0.015 (ie, 1.5% sequence divergence). For our analysis, if an individual did not have a sequence, we labeled him or her as not genetically clustered.

To capture aspects of SDOH, we used the following metrics at a zip code–level based on data from the ACS data (accessed using tidycensus in R software [27]): the proportion of individuals (1) under the poverty line (neighborhood poverty), (2) of Hispanic ethnicity, (3) who completed high school, (4) of white race (any ethnicity), and (5) employed. Using the genetic (sequence data, we calculated the proportion of individuals in a zip code that were genetically linked (neighborhood genetic clustering), including linkage within or across zip codes. SDOH metrics were associated with PWH based on their residential zip code. For analyses using late-stage HIV diagnosis as the outcome, the residential zip code at the time of diagnosis was used to determine SDOH values. In contrast, for analyses with in-care status and viral suppression as outcomes, the most recent residential zip code (as of 2022) was used. For consistency across all analyses, all SDOH metrics were based on 2021 values.

The proportions for all SDOH metrics were converted to binary high and low categories such that 50% of PWH in Clark County resided in a neighborhood labeled as high or low. For example, 50% of PWH in Clark County live in a zip code labeled as high poverty. Some zip codes in the region had incomplete ACS data. We excluded a total of 117 of 3714 individuals (3.2%) who had corresponding zip codes at diagnosis or current residence where ACS metrics were incomplete. Finally, we created a binary variable for each zip code indicating whether the area had an HIV testing site supported by SNHD. For clarity, at times, we refer to zip code–level predictors as neighborhood predictors.

Statistical Analysis

We conducted univariate and multivariate analyses. For our univariate analysis, we identified individual-level and zip code–level variables associated with our 3 outcomes by fitting generalized linear mixed-effects models (GLMMs) with a logit link function. The models were adjusted for clustering at the zip code level by using a random effect for intercept. We reported the regression coefficient (log odds ratio), SE, and P value from each univariate logistic regression model. We also generated geographic maps to examine the geospatial relationship of our outcomes.

For our multivariate analysis, we used GLMMs with an L1 penalty, that is LASSO (Least Absolute Shrinkage and Selection Operator) regression, to simultaneously conduct model selection and estimation [28, 29]. LASSO regression facilitates variable selection by applying a penalty term to the regression coefficients, effectively shrinking some coefficients to zero and thus achieving feature selection. To optimize the performance and find the best tuning parameter (λ), which controls the level of regularization, we adopted a cross-validation approach. Specifically, k-fold cross-validation was used, in which the dataset was divided into k = 10 subsets and each time 1 subset was held out as a validation set while the model was trained on the remaining k − 1 subsets. This process was repeated k times, and the average error was computed to determine the optimal λ whose mean prediction error was within 1 SE of the minimum mean prediction error. To estimate P values, a final reestimation was conducted, in which a model that includes only the variables corresponding to the nonzero fixed effects was fitted by simple Fisher scoring. Similar to the GLMMs, the LASSO models control for clustering at the zip code level using a random effect for intercept. We reported the regression coefficient (log odds ratio), SE, and P value. All analyses were conducted using R software (version 4.3.0).

RESULTS

Study Population Characteristics

There were 3597 PWH who both had HIV diagnosed and were residing in Clark County with zip code–level metrics (Table 1). The majority of them (3078 [86%]) were male. A total of 1266 (35%) were Hispanic of any race, while 1050 (29%) and 966 (27%) were black (non-Hispanic) and white (non-Hispanic), respectively. The majority of PWH (2372 [66%]) identified as men who have sex with men (MSM); however, 708 (20%) did not report any type of risk factor. The median age at HIV diagnosis was 32.8 years (range, 13.7–80.2 years). Of the study population, 1161 (32%) had ≥1 viral sequence collected. Based on our molecular analysis, 517 individuals were genetically linked (45% of those with a sequence) to ≥1 other individual in the county (Table 1).

Table 1.

Descriptive Statistics

Characteristic PWH, No. (%)a
Overall (n = 3597) Early-Stage HIV Diagnosis (n = 2781) Late-Stage HIV Diagnosis (n = 816) Not in Care (n = 760) In Care (n = 2837) Unsuppressed (n = 1133) Suppressed (n = 2464)
Individual-level predictors
Age at diagnosis, mean (range), y 35.5 (13.7–80.2) 34.2 (13.7–77.1) 39.7 (14.9–80.2) 33.1 (14.9–69.8) 36.1 (13.7–80.2) 33.7 (14.3–76.8) 36.3 (13.7–80.2)
Year of HIV diagnosis, mean (range)b 2017.2 (2011–2022) 2017.3 (2011–2022) 2016.7 (2011–2022) 2016.9 (2011–2022) 2017.3 (2011–2022) 2017.0 (2011–2022) 2017.3 (2011–2022)
Race/ethnicity
 Black 1050 (29) 815 (29) 235 (29) 266 (35) 784 (28) 406 (36) 644 (26)
 Hispanic 1266 (35) 980 (35) 286 (35) 258 (34) 1008 (36) 366 (32) 900 (37)
 Other 315 (8.8) 242 (8.7) 73 (8.9) 57 (7.5) 258 (9.1) 84 (7.4) 231 (9.4)
 White 966 (27) 744 (27) 222 (27) 179 (24) 787 (28) 277 (24) 689 (28)
Sex
 Female 519 (14) 383 (14) 136 (17) 113 (15) 406 (14) 165 (15) 354 (14)
 Male 3078 (86) 2398 (86) 680 (83) 647 (85) 2431 (86) 968 (85) 2110 (86)
Transmission risk factor
 Heterosexual contact 244 (6.8) 183 (6.6) 61 (7.5) 57 (7.5) 187 (6.6) 82 (7.2) 162 (6.6)
 IDU 127 (3.5) 95 (3.4) 32 (3.9) 22 (2.9) 105 (3.7) 40 (3.5) 87 (3.5)
 MSM 2372 (66) 1883 (68) 489 (60) 451 (59) 1921 (68) 676 (60) 1696 (69)
 MSM and IDU 140 (3.9) 111 (4.0) 29 (3.6) 32 (4.2) 108 (3.8) 48 (4.2) 92 (3.7)
 No reported risk 708 (20) 504 (18) 204 (25) 197 (26) 511 (18) 285 (25) 423 (17)
 Other 6 (0.2) 5 (0.2) 1 (0.1) 1 (0.1) 5 (0.2) 2 (0.2) 4 (0.2)
Sequence available
 No 2436 (68) 1904 (68) 532 (65) 605 (80) 1831 (65) 772 (68) 1664 (68)
 Yes 1161 (32) 877 (32) 284 (35) 155 (20) 1006 (35) 361 (32) 800 (32)
Genetic cluster
 No 3080 (86) 2358 (85) 722 (88) 709 (93) 2371 (84) 991 (87) 2089 (85)
 Yes 517 (14) 423 (15) 94 (12) 51 (6.7) 466 (16) 142 (13) 375 (15)
Zip code–level predictors, mean proportion mean (range)
 In cluster 0.1 (0.0–1.0) 0.1 (0.0–0.3) 0.1 (0.0–0.3) 0.1 (0.0–0.2) 0.1 (0.0–1.0) 0.1 (0.0–1.0) 0.1 (0.0–0.2)
 Below poverty level 0.2 (0.0–0.3) 0.2 (0.0–0.3) 0.2 (0.0–0.3) 0.2 (0.0–0.3) 0.2 (0.0–0.3) 0.2 (0.0–0.3) 0.2 (0.0–0.3)
 Hispanic ethnicity 0.4 (0.0–0.7) 0.4 (0.0–0.7) 0.4 (0.0–0.7) 0.4 (0.1–0.7) 0.4 (0.0–0.7) 0.4 (0.1–0.7) 0.4 (0.0–0.7)
 High school education (or above) 0.8 (0.6–1.0) 0.8 (0.6–1.0) 0.8 (0.6–1.0) 0.8 (0.6–1.0) 0.8 (0.6–1.0) 0.8 (0.6–1.0) 0.8 (0.6–1.0)
 White race 0.5 (0.3–0.9) 0.5 (0.3–0.9) 0.5 (0.3–0.9) 0.5 (0.3–0.9) 0.5 (0.3–0.9) 0.5 (0.3–0.9) 0.5 (0.3–0.9)
 Employment 0.9 (0.9–1.0) 0.9 (0.9–1.0) 0.9 (0.9–1.0) 0.9 (0.9–1.0) 0.9 (0.9–1.0) 0.9 (0.9–1.0) 0.9 (0.9–1.0)

Abbreviations: HIV, human immunodeficiency virus; IDU, injection drug user; MSM, men who have sex with men; PWH, people with HIV.

aData represent no. (%) of PWH unless otherwise specified.

bFor the year of HIV diagnosis, decimals represent the fraction of the year elapsed at the time of diagnosis.

In terms of SDOH, the average neighborhood poverty rate across all PWH based on current zip code was 20%, the average neighborhood unemployment rate was 10%, and the average neighborhood proportion without a high-school diploma was 20%. Within communities where PWH were currently living, the neighborhood proportion of non-Hispanic white individuals averaged 50%, and the average neighborhood proportion of Hispanic persons was 40% (Table 1).

Data visualizations of Clark County were created with zip codes colored based on whether the area has a high (yellow) or low (red) neighborhood poverty level (Figure 1A). As noted in Methods, we dichotomized neighborhoods such that roughly 50% of PWH are expected to reside in areas labeled as high poverty.

Figure 1.

Alt Text: Figure 1 includes 3 maps of Clark County, Nevada, displaying zip code–level data shaded by neighborhood poverty and with human immunodeficiency virus (HIV) care outcomes. Panel A maps ZIP codes by poverty level; high-poverty and low-poverty areas are shaded in different colors. Panel B overlays poverty level with the proportion of people with HIV (PWH) who are in care. Most high-poverty zip codes fall below the median for PWH in care, while most low-poverty zip codes—especially in the suburbs—are above the median. Panel C shows a similar pattern for viral suppression; high-poverty areas tend to have lower viral suppression rates, and low-poverty areas have higher rates. All panels highlight geographic disparities in HIV outcomes by poverty level.

A, Zip codes above and below median poverty rate among people with human immunodeficiency virus (HIV; PWH). B, Interaction between high versus low neighborhood poverty and high versus low rates of being in HIV care. C, Interaction between high versus low neighborhood poverty and high versus low rates of viral suppression. Circles are proportional in size to number of PWH in the zip codes. Regions with <10 PWH were excluded from visualization.

Late-Stage New Diagnoses

Of the 3597 PWH, 816 (23%) had late-stage HIV diagnosed (Table 1). Both univariate and multivariate analyses indicated that individual-level demographics and SDOH were associated with having a late-stage diagnosis. Individual-level predictors of late-stage diagnosis in our univariable analysis included older age at diagnosis (estimate [SE], 0.04 [3.4 × 10−3]) (Table 2). Lower rates of late-stage diagnosis were associated with later year of diagnosis (estimate [SE] −0.05 [6.6 × 10−4]), MSM status (−0.38 [8.5 × 10−2]), male sex at birth (−0.22 [0.11]), and individual-level genetic clustering (−0.31 [0.12]). We did not observe any SDOH factors associated with late-stage diagnosis in the univariate models.

Table 2.

Statistical Model Results for Late-Stage HIV Diagnosis

Predictor PWH by HIV Stage at Diagnosis, No./Total (%)a Univariate Analysis Multivariate Analysis
Early Stage
(n = 2781)
Late Stage
(n = 816)
Estimate (SE) P Value Estimate
(SE)
P Value
Individual-level predictors
 Year of HIV diagnosis, mean (range)b 2017.3 (2011–2022) 2016.7 (2011–2022) −0.05 (6.65 × 10−4) <.001c −0.06 (0.013) <.001c
 Age at diagnosis, mean (range), y 34.2 (13.7–77.1) 39.7 (14.9–80.2) 0.04 (0.003) <.001c 0.04 (0.003) <.001c
 Hispanic ethnicity 980/2781 (35) 286/816 (35) −0.01 (0.085) .92 0 (NA)
 IDU 206/2781 (7.4) 61/816 (7.5) 0.03 (0.153) .83 −0.1 (0.158) .52
 MSM 1994/2781 (72) 518/816 (63) −0.38 (0.085) <.001c −0.3 (0.112) .007d
 Male sex at birth 2398/2781 (86) 680/816 (83) −0.22 (0.11) .04e 0.16 (0.142) .26
 Genetic link 423/2781 (15) 94/816 (12) −0.31 (0.122) .01e −0.04 (0.13) .78
Zip code–level predictors
 Neighborhood genetic clustering 1359/2781 (49) 375/816 (46) −0.11 (0.104) .31 0.01 (0.092) .93
 Neighborhood poverty level 1311/2781 (47) 370/816 (45) −0.03 (0.108) .76 0.23 (0.165) .16
 Hispanic ethnicity 1376/2781 (49) 368/816 (45) −0.17 (0.103) .09 −0.18 (0.162) .26
 Educational level 1231/2781 (44) 379/816 (46) 0.09 (0.104) .38 −0.01 (0.173) .96
 White race 1379/2781 (50) 367/816 (45) −0.19 (0.102) .07 −0.27 (0.097) .005d
 Employment 1346/2781 (48) 434/816 (53) 0.18 (0.101) .08 0.28 (0.133) .03e
 HIV testing site 1024/2781 (37) 291/816 (36) −0.04 (0.111) .72 −0.09 (0.092) .30

Abbreviations: HIV, human immunodeficiency virus; IDU, injection drug user; MSM, men who have sex with men; NA, not applicable; PWH, people with HIV.

aData represent no./total (%) of PWH unless otherwise specified.

bFor the year of HIV diagnosis, decimals represent the fraction of the year elapsed at the time of diagnosis.

c P ≤ .001.

d P ≤ .01.

e P ≤ .05.

Based on the multivariate analysis (Table 2), we estimated similar associations in magnitude and direction for age at diagnosis (estimate [SE] 0.04 [3.5 × 10−3]), year of diagnosis (−0.06 [1.3 × 10−2]), and MSM status (−0.30 [0.11]). However, male sex at birth and individual genetic clustering were no longer significant. For SDOH factors, we found that a higher neighborhood proportion of white (non-Hispanic) residents (estimate [SE], −0.27 [9.7 × 10−2]) was associated with lower rates and a higher neighborhood proportion of employment (0.28 [0.13]) with higher rates of late-stage diagnosis.

Being in Care

Of the 3597 PWH, 2837 (79%) were identified as being in care (Table 1). Based on univariable analysis (Table 3), both individual-level demographics and SDOH were associated with being in care. Among individual-level predictors, older age at diagnosis (estimate [SE], 0.02 [3.8 × 10−3]), later year of diagnosis (0.04 [7.9 × 10−4]), MSM status (0.37 [8.7 × 10−2]), and individual-level genetic clustering (1.02 [0.15]) were associated with higher rates of being in care. For SDOH factors, a higher neighborhood proportion of residents with a high school diploma (or higher) in a zip code (estimate [SE], 0.19 [9.1 × 10−2]) was associated with higher rates of PWH being in care. A higher neighborhood proportion of residents under the poverty line in a zip code (estimate [SE], −0.27 [8.9 × 10−2]) was associated with lower rates of PWH in care.

Table 3.

Statistical Model Results for Being in HIV Care

Predictor PWH, No./Total (%)a Univariate Analysis Multivariate Analysis
Not in Care
(n = 760)
In Care
(n = 2837)
Estimate
(SE)
P Value Estimate
(SE)
P Value
Individual-level predictors
 Year of HIV diagnosis, mean (range)b 2016.9 (2011–2022) 2017.3 (2011–2022) 0.04 (7.89 × 10−4) <.001c 0.02 (0.013) .13
 Age at diagnosis, mean (range), y 33.1 (14.9–69.8) 36.1 (13.7–80.2) 0.02 (0.004) <.001c 0.03 (0.004) <.001c
 Hispanic ethnicity 258/760 (34) 1008/2837 (36) 0.07 (0.087) .41 0.13 (0.091) .15
 IDU 54/760 (7.1) 213/2837 (7.5) 0.08 (0.159) .63 0.08 (0.165) .63
 MSM 483/760 (64) 2029/2837 (72) 0.37 (0.087) <.001c 0.77 (0.113) <.001c
 Male sex at birth 647/760 (85) 2431/2837 (86) 0.04 (0.116) .70 −0.52 (0.146) <.001c
 Genetic link 51/760 (6.7) 466/2837 (16) 1.02 (0.154) <.001c 1.13 (0.16) <.001c
Zip code–level predictors
 Neighborhood genetic clustering 379/760 (50) 1395/2837 (49) −0.03 (0.096) .77 0 (NA)
 Neighborhood poverty 391/760 (51) 1274/2837 (45) −0.27 (0.089) .003d −0.42 (0.172) .02e
 Hispanic ethnicity 388/760 (51) 1338/2837 (47) −0.15 (0.093) .11 0.21 (0.176) .24
 Educational level 317/760 (42) 1325/2837 (47) 0.19 (0.091) .03e 0.05 (0.188) .79
 White race 356/760 (47) 1421/2837 (50) 0.13 (0.095) .16 0.01 (0.1) .96
 Employment 353/760 (46) 1435/2837 (51) 0.16 (0.093) .08 −0.02 (0.13) .86
 HIV testing site 285/760 (38) 989/2837 (35) −0.09 (0.1) .35 −0.1 (0.095) .28

Abbreviations: HIV, human immunodeficiency virus; IDU, injection drug user; MSM, men who have sex with men; NA, not applicable; PWH, people with HIV.

aData represent no./total (%) of PWH unless otherwise specified.

bFor the year of HIV diagnosis, decimals represent the fraction of the year elapsed at the time of diagnosis.

c P ≤ .001.

d P ≤ .01.

e P ≤ .05.

The multivariate analysis (Table 3) showed some slight differences. For individual-level predictors, we estimated similar associations in magnitude and direction as our univariate analyses for age at diagnosis (estimate [SE], 0.03 [4.1 × 10−3]), MSM status (0.77 [0.11]), and individual-level genetic clustering (1.13 [0.16]). However, year of diagnosis was no longer significant. In addition, we found that male sex at birth was associated with a lower rate of PWH being in care. For SDOH predictors, a higher neighborhood proportion of residents under poverty line (estimate [SE], −0.42 [0.17]) was significant and similar to univariate results; however, the education level of residents in a zip code was no longer significant. Therefore, neighborhood poverty level was the only significant SDOH predictor we identified, and it was inversely associated with PWH being in care.

The interaction between high and low rates of PWH in care and poverty by zip code were investigated (Figure 1B), almost all areas labeled as high neighborhood poverty were also below the median level of PWH being in care. Inversely, areas labeled as low poverty in the suburbs of Clark County were almost all above the median level of PWH in care.

Viral Suppression

Of the 2837 of 3597 PWH (79%) in care, 2464 of 3597 (69%) were virally suppressed (Table 1). A total of 373 of 2837 (13%) were in care and not virally suppressed. Based on univariable analysis (Table 4), we identified the following individual-level predictors associated with higher rates of viral suppression: older age at diagnosis (estimate [SE]. 0.02 [3.3 × 10−3]), later year of diagnosis (0.02 [6.7 × 10−4), MSM status (0.40 [7.7 × 10−2]), being Hispanic (0.20 [7.7 × 10−2]), and individual-level genetic clustering (0.25 [0.11]). For SDOH predictors, high neighborhood employment rate (estimate [SE], 0.24 [8.9 × 10−2]) and high neighborhood proportion with a high school diploma (0.27 [8.8 × 10−2]) at the zip code level were associated with higher rates of viral suppression among PWH, while high neighborhood poverty rate (−0.38 [8.0 × 10−2]), and high neighborhood proportion of Hispanic residents in a zip code (−0.27 [8.8 × 10−2]) were associated lower rates of viral suppression among PWH.

Table 4.

Statistical Model Results for Being Viral Suppressed

Predictor PWH, No./Total (%)a Univariate Analysis Multivariate Analysis
Virally Unsuppressed
(n = 1133)
Virally Suppressed
(n = 2464)
Estimate (SE) P Value Estimate
(SE)
P Value
Individual-level predictors
 Year of HIV diagnosis, mean (range)b 2017.0 (2011–2022) 2017.3 (2011–2022) 0.02 (6.7 × 10−4) <.001c 0.02 (0.011) .11
 Age at diagnosis, mean (range), y 33.7 (14.3–76.8) 36.3 (13.7–80.2) 0.02 (0.003) <.001c 0.03 (0.003) <.001c
 Hispanic ethnicity 366/1133 (32) 900/2464 (37) 0.2 (0.077) .009d 0.22 (0.08) .006d
 IDU 88/1133 (7.8) 179/2464 (7.3) −0.05 (0.137) .71 −0.02 (0.14) .88
 MSM 724/1133 (64) 1788/2464 (73) 0.4 (0.077) <.001c 0.51 (0.082) <.001c
 Male sex at birth 968/1133 (85) 2110/2464 (86) 0.02 (0.103) .86 0 (NA)
 Genetic link 142/1133 (13) 375/2464 (15) 0.25 (0.107) .02e 0.3 (0.113) .007d
Zip code–level predictors
 Neighborhood genetic clustering 588/1133 (52) 1186/2464 (48) −0.15 (0.096) .11 0.04 (0.092) .68
 Neighborhood poverty 598/1133 (53) 1067/2464 (43) −0.38 (0.08) <.001c −0.48 (0.15) .001d
 Hispanic ethnicity 599/1133 (53) 1127/2464 (46) −0.27 (0.088) .002d 0.04 (0.153) .79
 Educational level 462/1133 (41) 1180/2464 (48) 0.27 (0.088) .002d −0.03 (0.166) .85
 White race 535/1133 (47) 1242/2464 (50) 0.14 (0.096) .16 −0.02 (0.093) .83
 Employment 512/1133 (45) 1276/2464 (52) 0.24 (0.089) .007d −0.01 (0.112) .96
 HIV testing site 424/1133 (37) 850/2464 (34) −0.1 (0.102) .31 −0.1 (0.083) .23

Abbreviations: HIV, human immunodeficiency virus; IDU, injection drug user; MSM, men who have sex with men; NA, not applicable; PWH, people with HIV.

aData represent no./total (%) of PWH unless otherwise specified.

bFor the year of HIV diagnosis, decimals represent the fraction of the year elapsed at the time of diagnosis.

c P ≤ .001.

d P ≤ .01.

e P ≤ .05.

Based on the multivariate analysis (Table 4), we estimated similar associations in direction for viral suppression and age of diagnosis (estimate [SE], 0.03 [3.4 × 10−3]), MSM status (0.51 [8.2 × 10−2]), being Hispanic (0.22 [8.0 × 10−2]), individual-level genetic clustering (0.30 [0.11]), and high neighborhood poverty rate (−0.48 [0.15]). However, year of HIV diagnosis and neighborhood proportions (within zip code of residence) of Hispanic ethnicity, with a high school diploma, and employed were no longer significant. Therefore, we found that the neighborhood poverty rate was the only SDOH predictor associated with viral suppression in our multivariate analysis. The interaction between high and low rates of viral suppression and neighborhood poverty by zip code (Figure 1C) shows a similar pattern as being in care (Figure 1B).

DISCUSSION

In summary, we found a statistically significant association with individual-level demographic characteristics for all 3 HIV care continuum steps in our multivariate analysis. In particular, MSM status was associated with improved outcomes in terms of lower rates of late-stage diagnosis, and higher probability of being in care and virally suppressed. Being older at HIV diagnosis is associated with higher probability of late-stage diagnosis; however, older age at diagnosis is associated with having a higher probability of being in care and being virally suppressed. Finally, individuals who were genetically linked have a higher probability of being in care and virally suppressed.

Regarding SDOH, we observed that neighborhood poverty was significantly associated with HIV care continuum stages in our multivariate analysis. Specifically, neighborhood poverty was associated with lower probability of being in care and viral suppression. In contrast, zip codes in the outermost regions of Clark County had below-median levels of PWH being in care even though they were low poverty; therefore, these geographic regions are areas that may benefit from additional linkage and adherence services.

The association of neighborhood poverty and poorer outcomes along the care continuum (ie, not receiving medical care and viral nonsuppression) aligns with findings of previous research [30–33] and conceptual theories of the impact of poverty on medical care [34]. Most previous research focused on community-level socioeconomic status identified an association between higher neighborhood poverty levels and increased HIV diagnosis rates [11, 32]. Research looking at HIV clinical outcomes identified an association between neighborhood poverty and increased mortality rates among PWH [33], lower CD4+ cell counts [31], and lower level of viral suppression [30]. Conceptual theories for these associations include limitations in transportation that may negatively affect HIV linkage to care in high-poverty areas [34]. Other studies support the association of poverty stigma with lower rates of medical visits and viral suppression [35]. Furthermore, research indicates that issues related to poverty—specifically, food insufficiency and hunger—may result in nonadherence to HIV treatment [36]. These findings collectively underscore the complex interplay between socioeconomic factors and HIV outcomes, emphasizing the need for targeted interventions to address disparities in vulnerable communities. Interventions such as universal basic income and rideshare and public transportation programs to offer transportation to HIV care visits are possible targeted interventions to reduce disparities.

Here we noted a positive association with individual-level genetic clustering and progression through the HIV care continuum. There are a few possible interpretations of this result. First, earlier diagnosis is frequently associated with a greater frequency of genetic clustering and subsequent greater linkage and engagement in care. Another possibility is that testing and sequencing are skewed to populations that are more willing to engage and participate in the health system. In this scenario, the new diagnoses that do not genetically link to others (ie, potentially presenting with later-stage HIV) might deserve evaluation of more focused strategies to link and engage these PWH in care.

Our analysis has several limitations. One limitation is that only 32% of individuals have ever had their HIV genome sequenced, which may influence estimates for the association between HIV care continuum stage and genetic clustering. We coded those without a sequence as not being clustered, thus treating individuals with a missing sequence and those with a sequence but not clustered as the same. Furthermore, not adjusting for missing sequence would likely result in lower estimates of clustering with a zip code compared with the true level of clustering. However, recent statistical advances may begin to address this challenge of missing network data [37, 38]. Another limitation is that the HIV sequences used in our analysis were only 500 base pairs; however, we do not anticipate longer sequences to substantially change our findings. In addition to these limitations, the design of our study may impede generalizing our findings to all PWH in Clark County. In particular, we restricted our analysis to individuals whose HIV was diagnosed and who are currently living in Clark County. The progression through the HIV care continuum may be different for those who move into or out of Clark County.

The findings of this study have implications for healthcare providers, policy makers, and public health agencies involved in HIV care and prevention in Clark County. By identifying the predictors that are positively and negatively associated with outcomes along the HIV care continuum, interventions can be designed to address the unique needs and barriers faced by individuals at different stages of the care continuum. Moreover, the results may inform the allocation of resources, development of focused outreach programs, and implementation of evidence-based social, structural, and prevention strategies to improve overall HIV care outcomes in the region. In particular, our findings highlight the need for linking and engaging individuals in higher-poverty neighborhoods to medical providers. Furthermore, our results support additional treatment adherence services in those same neighborhoods to increase viral suppression rates.

Acknowledgments

Author contributions. R. G. and SJL and conceived of the presented idea. R. G. and A. W. conducted the statistical analyses. V. B., A. S., P. T., S. R. M., J. D., and S. J. L. aided in interpreting the results and worked on the manuscript. All authors discussed the results and commented on the manuscript.

Financial support. This work was supported by the National Institutes of Health (grants P30 AI036214, R01 AI147441, and R01 MH132151) and the James B. Pendleton Charitable Trust.

Contributor Information

R Goyal, Department of Medicine, University of California San Diego, San Diego, California, USA.

A Wells, Department of Medicine, University of California San Diego, San Diego, California, USA.

V Burris, Southern Nevada Health District, Las Vegas, Nevada, USA.

A Stachnik, Southern Nevada Health District, Las Vegas, Nevada, USA.

P Tang, Nevada Department of Human Services, Carson City, Nevada, USA.

L Collins, Nevada Department of Human Services, Carson City, Nevada, USA.

S R Mehta, Department of Medicine, University of California San Diego, San Diego, California, USA; Department of Medicine, VA Medical Center San Diego, San Diego, California, USA.

J Dufresne, Healthcare Consultant, Louisville, Colorado, USA.

S J Little, Department of Medicine, University of California San Diego, San Diego, California, USA.

References

  • 1. Bosh  KA, Hall  HI, Eastham  L, Daskalakis  DC, Mermin  JH. Estimated annual number of HIV infections—United States, 1981–2019. Morb Mortal Wkly Rep  2021; 70:801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Linley  L., Johnson  AS, Song  R, Hu  S, Wu  B, Hall  HI. Estimated HIV incidence and prevalence in the United States 2010–2019. 2021.
  • 3. Hacker  K, Auerbach  J, Ikeda  R, Philip  C, Houry  D. Social determinants of health—an approach taken at CDC. J Public Health Manag Pract  2022; 28:589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Hogan  JW, Galai  N, Davis  WW. Modeling the impact of social determinants of health on HIV. AIDS Behav  2021; 25:215–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Patel  D, Clark  HA, Williams  WO, Taylor-Aidoo  N, Wright  C. CDC-funded HIV testing services outcomes and social determinants of health in ending the HIV epidemic in the US jurisdictions. AIDS Behav  2024:28:1152–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Jeffries  WL, Henny  KD. From epidemiology to action: the case for addressing social determinants of health to end HIV in the Southern United States. AIDS Behav  2019; 23:340–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Menza  TW, Hixson  LK, Lipira  L, Drach  L. Social determinants of health and care outcomes among people with HIV in the United States. Open Forum Infect Dis  2021; 8:ofab330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. De Jesus  M, Williams  DR. The care and prevention in the United States demonstration project: a call for more focus on the social determinants of HIV/AIDS. Public Health Rep  2018; 133:28S–33S. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Kay  ES, Batey  DS, Mugavero  MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther  2016; 13:35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Denning  P, DiNenno  E. Communities in crisis: is there a generalized HIV epidemic in impoverished urban areas of the United States. Presented at: XVIII International AIDS Conference; July 18–23, 2010, Vienna, Austria; 2010; 1. [Google Scholar]
  • 11. Gant  Z, Lomotey  M, Hall  HI, et al.  A county-level examination of the relationship between HIV and social determinants of health: 40 states, 2006–2008. Open AIDS J  2012; 6:1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Kerr  J, Smith  A, Nzama  N, et al.  Systematic review of neighborhood factors impacting HIV care continuum participation in the United States. J Urban Health  2024; 101:31–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Terzian  AS, Younes  N, Greenberg  AE, et al.  Identifying spatial variation along the HIV care continuum: the role of distance to care on retention and viral suppression. AIDS Behav  2018; 22:3009–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Tymejczyk  O, Jamison  K, Pathela  P, et al.  HIV care and viral load suppression after sexual health clinic visits by out-of-care HIV-positive persons. AIDS Patient Care STDs  2018; 32:390–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Chen  YT, Duncan  DT, Issema  R, et al.  Social-environmental resilience, PrEP uptake, and viral suppression among young black men who have sex with men and young black transgender women: the neighborhoods and networks (N2) study in Chicago. J Urban Health  2020; 97:728–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Olatosi  B, Weissman  S, Zhang  J, et al.  Neighborhood matters: impact on time living with detectable viral load for new adult HIV diagnoses in South Carolina. AIDS Behav  2020; 24:1266–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Sheehan  DM, Fennie  KP, Mauck  DE, et al.  Retention in HIV care and viral suppression: individual- and neighborhood-level predictors of racial/ethnic differences, Florida, 2015. AIDS Patient Care STDs  2017; 31:167–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Dennis  AM, Mobley  V. Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?  Expert Rev Anti Infect Ther  2023; 21:691–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Sullivan  PS, et al.  Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the US ending the HIV epidemic jurisdictions. Ann Epidemiol  2020; 44:16–30. [DOI] [PubMed] [Google Scholar]
  • 20. State of Nevada . 2022 HIV fast facts. Off HIV Div Public Behav Health  2023:e1.0. [Google Scholar]
  • 21. Nevada Department of Health and Human Services . Clark County Ending the HIV Epidemic plan. 2020. https://endhivnevada.org/wp-content/uploads/2020/09/PS19-1906-Nevada-Clark-County-EHE-FINAL-Plan.pdf
  • 22. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2020. 2022.
  • 23. Centers for Disease Control and Prevention (CDC) . Revised surveillance case definition for HIV infection—United States, 2014. MMWR Recomm Rep  2014; 63:1–10. [PubMed] [Google Scholar]
  • 24. Hall  HI, Tang  T, Espinoza  L. Late diagnosis of HIV infection in metropolitan areas of the United States and Puerto Rico. AIDS Behav  2016; 20:967–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Centers for Disease Control and Prevention . HIV treatment as prevention. HIV Public Health Partners. 2025. Available at: https://www.cdc.gov/hivpartners/php/hiv-treatment/index.html. Accessed August 5, 2025.
  • 26. Tamura  K, Nei  M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol  1993; 10:512–26. [DOI] [PubMed] [Google Scholar]
  • 27. Walker  K, Herman  M. _tidycensus: Load US Census Boundary and Attribute Data as ‘tidyverse’ and ‘sf’-Ready Data Frames_. R package version 1.7.1, 2025.
  • 28. Tibshirani  R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B Stat Methodol  1996; 58:267–88. [Google Scholar]
  • 29. Groll  A, Tutz  G. Variable selection for generalized linear mixed models by L1-penalized estimation. Stat Comput  2014; 24:137–54. [Google Scholar]
  • 30. Xia  Q, Robbins  RS, Lazar  R, Torian  LV, Braunstein  SL. Racial and socioeconomic disparities in viral suppression among persons living with HIV in New York City. Ann Epidemiol  2017; 27:335–41. [DOI] [PubMed] [Google Scholar]
  • 31. Wiewel  EW, Borrell  LN, Jones  HE, Maroko  AR, Torian  LV. Neighborhood characteristics associated with achievement and maintenance of HIV viral suppression among persons newly diagnosed with HIV in New York City. AIDS Behav  2017; 21:3557–66. [DOI] [PubMed] [Google Scholar]
  • 32. Fede  ALD, Stewart  JE, Hardin  JW, Mayfield-Smith  K, Sudduth  D. Spatial visualization of multivariate datasets: an analysis of STD and HIV/AIDS diagnosis rates and socioeconomic context using ring maps. Public Health Rep  2011; 126:115–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Joy  R, Druyts  EF, Brandson  EK, et al.  Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr  2008; 47:500–5. [DOI] [PubMed] [Google Scholar]
  • 34. Goswami  ND, Schmitz  MM, Sanchez  T, et al.  Understanding local spatial variation along the care continuum: the potential impact of transportation vulnerability on HIV linkage to care and viral suppression in high-poverty areas, Atlanta, Georgia. J Acquir Immune Defic Syndr  2016; 72:65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Leddy  AM, Turan  JM, Johnson  MO, et al.  Poverty stigma is associated with suboptimal HIV care and treatment outcomes among women living with HIV in the United States. AIDS  2019; 33:1379–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Kalichman  SC, Grebler  T. Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS. Psychosom Med  2010; 72:810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Krause  RW, Huisman  M, Steglich  C, Snijders  T. Missing data in cross-sectional networks–an extensive comparison of missing data treatment methods. Soc Netw  2020; 62:99–112. [Google Scholar]
  • 38. Goyal  R, Nguyen  K, De Gruttola  V, Little  SJ, Cohen  C, Martin  NK. Investigating the HIV epidemic in Miami using a novel approach for bayesian inference on partially observed networks. arXiv [Preprint: not peer reviewed]. 23 July 2024. Available from: http://arxiv.org/abs/2407.16135.

Articles from Open Forum Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES